Use of continuous glucose monitoring devices positively correlated with fewer sleep disturbances in children with type 1 diabetes but higher sleep disturbances in their parents.
Companion Medical announced that it has received clearance from the Food and Drug Administration (FDA) for a new bolus calculator for fixed dosing and meal estimation to be used with the InPen system.
Access to a patient portal through both mobile and computer platforms was associated with significantly improved outcomes in diabetes management.
Medtronic is recalling certain MiniMed 600 Series insulin pumps due to a missing or broken retainer ring that can potentially lead to the under or over delivery of insulin.
A novel dual-hormone artificial pancreas system that delivers both rapid insulin and pramlintide was found to improve glucose control.
Real-world use of continuous glucose monitoring systems improves glycemic control and reduces the frequency of rare and dangerous events in pediatric type 1 diabetes.
Automated insulin delivery by a mobile closed-loop control system represents a feasible option for glycemic control in type 1 diabetes, with some improvements still needed in device connectivity.
Researchers explored the effects of a telemedicine visit on care in patients with T1D.
Intermittently scanned continuous glucose monitoring results in higher treatment satisfaction among adults with type 1 diabetes.
The American Diabetes Association (ADA) has published an update to their Standards of Medical Care in Diabetes for 2020.
